Type I collagen is the major component of connective tissue. Excessive accumulation of Type I collagen in the skin and internal organs is the hallmark of scleroderma, a progressive and currently incurable disease. The pathogenesis of scleroderma is not well understood. During the past 5 years, data generated from several lines of investigations have suggested that transforming growth factor-beta (TGF-beta) plays a critical role in the development of fibrosis in human diseases and experimental animal models. In scleroderma, elevated expression of TGF-beta has been demonstrated in affected tissues. We and others have shown that TGF-beta stimulates the synthesis of Types I, III, and VII collagens, and other components of the extracellular matrix. We have recently obtained evidence that the expression of the human alpha 1 Type I collagen gene (COL1A1) is increased by TGF-beta via a cis-acting element in the proximal promoter of the gene. The overall goal of the present project is to examine the molecular basis of stimulation of Type I collagen synthesis in normal human skin fibroblasts in response to TGF-beta.
In Specific Aim 1, cis- acting elements in human COL1A1 mediating responsiveness to TGF-beta will be identified and characterized by deletion analysis, mapping and functional studies.
In Specific Aim 2, the interaction of these putative regulatory elements with nuclear trans-acting proteins will be examined.
In Specific Aim 3, the genes coding for DNA-binding nuclear proteins which interact with TGF-beta-responsive elements in the COL1A1 promoter will be isolated from human fibroblast cDNA libraries. The positive clones will be sequenced and characterized. Understanding the molecular events involved in the stimulation of human COL1A1 expression by TGF-beta in this in vitro model will enhance our understanding of collagen gene regulation. These insights may lead to the development of specific agents which interfere with TGF-beta-induced collagen accumulation, and can be useful in the treatment of scleroderma.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR042309-04
Application #
2006323
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1993-12-01
Project End
1998-11-30
Budget Start
1996-12-01
Budget End
1997-11-30
Support Year
4
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Illinois at Chicago
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
121911077
City
Chicago
State
IL
Country
United States
Zip Code
60612
Bhattacharyya, Swati; Varga, John (2018) Endogenous ligands of TLR4 promote unresolving tissue fibrosis: Implications for systemic sclerosis and its targeted therapy. Immunol Lett 195:9-17
Cooper, John G; Jeong, Su Ji; McGuire, Tammy L et al. (2018) Fibronectin EDA forms the chronic fibrotic scar after contusive spinal cord injury. Neurobiol Dis 116:60-68
Korman, Benjamin; Marangoni, Roberta Goncalves; Lord, Gabriel et al. (2018) Adipocyte-specific Repression of PPAR-gamma by NCoR Contributes to Scleroderma Skin Fibrosis. Arthritis Res Ther 20:145
Marangoni, Roberta G; Masui, Yuri; Fang, Feng et al. (2017) Adiponectin is an endogenous anti-fibrotic mediator and therapeutic target. Sci Rep 7:4397
Wei, Jun; Zhu, Hongyan; Lord, Gabriel et al. (2017) Nrf2 exerts cell-autonomous antifibrotic effects: compromised function in systemic sclerosis and therapeutic rescue with a novel heterocyclic chalcone derivative. Transl Res 183:71-86.e1
Bhattacharyya, Swati; Wang, Wenxia; Morales-Nebreda, Luisa et al. (2016) Tenascin-C drives persistence of organ fibrosis. Nat Commun 7:11703
Reinke, Lauren; Lam, Anna P; Flozak, Annette S et al. (2016) Adiponectin inhibits Wnt co-receptor, Lrp6, phosphorylation and ?-catenin signaling. Biochem Biophys Res Commun 470:606-612
Bhattacharyya, Swati; Wang, Wenxia; Graham, Lauren Van Duyn et al. (2016) A20 suppresses canonical Smad-dependent fibroblast activation: novel function for an endogenous inflammatory modulator. Arthritis Res Ther 18:216
Taroni, Jaclyn N; Martyanov, Viktor; Huang, Chiang-Ching et al. (2015) Molecular characterization of systemic sclerosis esophageal pathology identifies inflammatory and proliferative signatures. Arthritis Res Ther 17:194
Lakota, Katja; Carns, Mary; Podlusky, Sofia et al. (2015) Serum amyloid A is a marker for pulmonary involvement in systemic sclerosis. PLoS One 10:e0110820

Showing the most recent 10 out of 90 publications